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Abstract
The human gut microbiota is increasingly recognized as a player in colorectal cancer (CRC). While particular imbalances in
the gut microbiota have been linked to colorectal adenomas and cancer, no specific bacterium has been identified as a risk
factor. Recent studies have reported a high abundance of Fusobacterium in CRC subjects compared to normal subjects, but
this observation has not been reported for adenomas, CRC precursors. We assessed the abundance of Fusobacterium species
in the normal rectal mucosa of subjects with (n = 48) and without adenomas (n = 67). We also confirmed previous reports on
Fusobacterium and CRC in 10 CRC tumor tissues and 9 matching normal tissues by pyrosequencing. We extracted DNA from
rectal mucosal biopsies and measured bacterial levels by quantitative PCR of the 16S ribosomal RNA gene. Local cytokine
gene expression was also determined in mucosal biopsies from adenoma cases and controls by quantitative PCR. The mean
log abundance of Fusobacterium or cytokine gene expression between cases and controls was compared by t-test. Logistic
regression was used to compare tertiles of Fusobacterium abundance. Adenoma subjects had a significantly higher
abundance of Fusobacterium species compared to controls (p = 0.01). Compared to the lowest tertile, subjects with high
abundance of Fusobacterium were significantly more likely to have adenomas (OR 3.66, 95% CI 1.37–9.74, p-trend 0.005).
Cases but not controls had a significant positive correlation between local cytokine gene expression and Fusobacterium
abundance. Among cases, the correlation for local TNF-a and Fusobacterium was r = 0.33, p = 0.06 while it was 0.44, p = 0.01
for Fusobacterium and IL-10. These results support a link between the abundance of Fusobacterium in colonic mucosa and
adenomas and suggest a possible role for mucosal inflammation in this process.
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Introduction
The human intestinal microbiota inhabits a complex and diverse
environment populated by hundreds of different bacterial species.
The number of bacterial cells in the gut exceeds all other eukaryotic
cells in the human body by a factor of 10 [1,2]. These bacteria are
regulated in the gut by the mucosal immune system, which is made
up of a complex network of functions and immune responses aimed
at maintaining a cooperative system between the intestinal
microbiota and the host [1]. In a healthy gut these bacteria maintain
homeostasis with the host. However, when an imbalance, or
bacterial dysbiosis, occurs in the gut, the host may experience
inflammation and a loss of barrier function [3,4]. Bacterial dysbioses
have been linked to several diseases including ulcerative colitis,
Crohn’s disease [5–7] and colorectal cancer (CRC) [8,9]. Current
research is focused on identifying key players in this imbalance as
well as their specific contribution to colorectal carcinogenesis.
No single bacterial species has been identified as a risk factor for
CRC, but recent studies report an increase in the abundance of
Fusobacterium in human colorectal tumors compared to controls
[8,10,11]. These studies suggest that Fusobacterium may be associated
with the later stages of CRC, but it is unknown if they play a role in
the early stages of colorectal carcinogenesis. While the causes of
colorectal cancer are not fully known, it is becoming increasingly
clear that the gut microbiota provide an important contribution
[12].
We evaluated whether Fusobacterium nucleatum in normal rectal
mucosal biopsies was associated with colorectal adenomas. We also
examined a potential association between local inflammation and
abundance of Fusobacterium in adenoma cases and non-adenoma
controls. We found that Fusobacterium was more abundant in
adenoma cases than controls. We observed significant positive
correlation between IL-10 and TNF-a gene expression and
abundance of Fusobacterium species in cases. Validation experiments
were performed using CRC tissue and matching normal tissue to
confirm previous reports of an association between CRC and
Fusobacterium.
Results
Studies in Normal Rectal Mucosa of Adenoma and Non-
adenoma Subjects
Fusobacterium abundance is higher in adenoma cases
compared to controls. We evaluated Fusobacterium species in
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normal mucosal biopsies from 115 subjects, 48 cases and 67
controls by qPCR. Subject characteristics are shown in Table 1.
All subjects were similar in age with cases having a mean age of
56.3860.92, and controls 55.9060.88 years. There were no
significant differences between adenoma cases and non-adenoma
controls for several risk factors evaluated including alcohol intake,
caloric intake, waist-hip ratio, body mass index and total fat intake.
Abundance of Fusobacterium species was significantly higher in
adenoma cases compared to controls (mean log copy number and
standard error, cases, 8.4460.38; controls 7.4060.22 p = 0.01)
(Fig. 1). Compared to those with low abundance of Fusobacterium,
those with high abundance of Fusobacterium were more likely to be
adenoma cases (p-trend = 0.005) (Table 2). We also assessed the
correlation between Fusobacterium abundance and the frequency
and size (small, medium, large) of adenomas among cases. There
was no significant correlation between Fusobacterium species and
adenoma size (Table S1) or number of adenomas (r = 20.08,
p = 0.57).
Localization of Fusobacterium in colonic mucosal by FISH
analysis. We Observed that Fusobacterium was over-represented
in adenoma cases compared to non-adenoma controls, therefore,
we performed histological evaluation by Fluorescence in situ
Hybridization (FISH) using a Fusobacterium-specific probe to
localize Fusobacterium in colonic mucosal tissue sections (Fig. 2a
and 2b). The results show that Fusobacterium was localized in the
mucus layer above the epithelium as well as within the colonic
crypts. A general bacterial probe was also used as a positive control
(Fig. 2c). Results confirm the presence of bacteria in the mucus
layer.
There is a significant positive correlation between
Fusobacterium species abundance and local inflammation
in adenoma cases. Correlation of local inflammatory cytokine
gene expression and Fusobacterium species abundance was analyzed
separately for adenoma cases and non-adenoma controls. Analysis
of cytokines IL-6, IL-10, IL-12, IL-17 and TNF-a and Fusobac-
terium was observed to have a significant positive correlation with
local inflammation in cases, but not controls (Fig. 3). A significant
positive correlation was found between abundance of Fusobacterium
species and IL-10 (r = 0.443 p = 0.01). The correlation for TNF-a
(r = 0.335 p = 0.06) was borderline significant. Although the
correlations for IL-6 and IL-17 were positive, they did not reach
statistical significance.
Figure 1. Abundance of Fusobacterium in rectal mucosal biopsies from adenoma cases and non-adenoma controls. qPCR results show
that Fusobacterium is more abundant in cases than controls.
doi:10.1371/journal.pone.0053653.g001
Table 1. Characteristics of Study Participants.
Characteristic Case (n = 48) Control (n = 67) P-value























Table 2. Association between Fusobacterium abundance and
colorectal adenomas.
Categories* Case (n = 48) Control (n = 67) OR (95% CI)**
Tertile 1 8 23 Reference
Tertile 2 12 22 1.57 (0.54–4.57)
Tertile 3 28 22 3.66 (1.37–9.74)
P trend
*The abundance of Fusobacterium among control subjects were used to
generate tertile cut-off. The lowest tertile of Fusobacterium abundance was
considered as the reference.
**Odds ratio and 95% confidence interval.
Compared to subjects with a low copy number, subjects with high abundance
of Fusobacterium are more likely to be adenoma cases than controls.
doi:10.1371/journal.pone.0053653.t002
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Confirmatory Studies in Colorectal Cancer
Pyrosequencing analysis of 16s rRNA gene in colorectal
cancer (CRC) tissue and matched normal colonic tissue
revealed higher Fusobacterium species abundance in CRC
compared to normal tissue. Previous studies reported an
association between Fusobacterium species and colorectal cancer
[8,10,11]. We reproduced these results by conducting high-
throughput pyrosequencing analysis on 19 matched samples, 10
CRC tissues and 9 non-malignant matched controls from adjacent
mucosa. All subjects were Caucasian and predominantly female,
with ages ranging from 37–78 years. High-throughput sequencing
revealed differences in abundance and richness in CRC compared
to normal tissue. We identified 13 phyla, 24 classes and 176
bacteria genera. Overall, Shannon diversity and richness were
higher in the CRC samples than matched normal tissue.
Abundance of individual bacteria varied between groups. We
observed reduced abundance of Bacteroidetes in CRC tissue
compared to normal colon tissue, however, the distribution of the
phylum Fusobacteria was higher in CRC tissue. The results
showed a higher abundance of Fusobacterium in the CRC tissue
compared to normal tissue. (Fig. 4).
qPCR validation of Fusobacterium species in colorectal
cancer patients. qPCR analysis of Fusobacterium species in 10
CRC and 9 matching normal control tissues revealed a significant
increase in abundance among colorectal cancer tissue compared to
normal tissue, confirming previously reported results of higher
Fusobacterium abundance in CRC patients. We also evaluated the
relationship between CRC characteristics such as tumor location,
treatment and Fusobacterium abundance. We did not observe
significant associations for most of the tumor characteristics;
however, we observed higher abundance of Fusobacterium species in
the sigmoid than right side tumor location (Table 3). We further
validated the pyrosequencing results by qPCR and observed
significantly positive correlation between the two methods
(r = 0.76, p = 0.0001).
Discussion
The human gut microbiota has been shown to have a dynamic
and observable impact on the human host [4,13]. While many of
these bacteria are commensal and facilitate the maintenance of a
healthy and functioning gastrointestinal tract, current research has
shown that interactions between the host and the bacteria
colonizing the gut can contribute to various diseases including
colorectal carcinogenesis [12–15]. In particular, bacterial dysbiosis
in the gut has been implicated in colorectal neoplasia, although no
specific bacteria or bacterial signatures have been identified for
colorectal adenomas [8,9]. We evaluated the abundance of
Fusobacterium in relation to colorectal adenomas in a case-control
study and found that compared to controls, cases had significantly
higher abundance of Fusobacterium.
There has been a recent focus on Fusobacterium, Gram-negative
bacteria that usually colonize the oral cavity [10,16]. Several
groups have identified Fusobacterium in tumors of patients with
colorectal carcinoma [8,10,17–19] and reported that the tumor
tissue was characterized by a higher abundance of Fusobacterium
than that of the normal colon. These results suggest Fusobacterium
as a potential biomarker for colorectal carcinogenesis. However, it
is not known whether Fusobacterium is associated with adenomas,
early precursors of CRC. We observed significant differences in
bacterial abundance between adenoma versus non-adenoma
subjects and found that there was a strong positive correlation
between high abundance of Fusobacterium and the presence of
colorectal adenomas (p = 0.01). In particular those with high levels
of Fusobacterium had about three and half fold increased risk of
adenomas. As a CRC precursor, adenomas have become
increasingly important in the study of colorectal carcinogenesis.
Our results suggest that the changes in gut microbiota are
associated with the earliest stages of tumor development [20]. Our
results for colorectal adenomas and increased Fusobacterium levels
are similar to previously reported studies involving Fusobacterium
and colorectal cancer [8,10,11]. We validated the previously
Figure 2. Representative fluorescence in situ hybridization
targeting Fusobacterium sp. in colorectal mucosal biopsy
sections using bacterial 16S rRNA probes. Fig. 2A–B are
composite images of Cy3 and DAPI views of sections hybridized with
a Fusobacterium-specific probe. Fusobacterium species is localized
within the mucus layer of colorectal sections (A) 20X and 40X.
Fusobacterium species is localized within the crypts of colorectal
section (B) 20X and 40X. Fig. 2C (20X and 40X) is a positive control and
shows sections stained with general bacteria probe (Eub 388). General
bacteria, including most Eubacteria species, are localized to the mucus
layer above the epithelium. White arrows point to bacteria either in
mucus layer above the colonic epithelium or within the crypt.
doi:10.1371/journal.pone.0053653.g002
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reported association between Fusobacterium and colorectal carcino-
ma in a set of matched CRC tumor and normal human colon
tissue samples. Using both pyrosequencing and qPCR analysis of
the 16S bacterial rRNA gene we were able to successfully
reproduce these published results. We found that among CRC
tumors and matched controls, Fusobacterium abundance was
significantly higher in tumor tissue based on both qPCR as well
as pyrosequencing analysis, with a significant correlation between
both methods (r = 0.76, p = 0.0001).
We and others observed a difference in Fusobacterium abundance
between the colorectal tumor and adjacent non-neoplastic tissue
[10,11], however, it would also be beneficial in future studies to
Figure 3. Correlations between Fusobacterium abundance and local cytokine gene expression in adenoma cases and non-adenoma
controls. Results suggest a significant positive correlation between Fusobacterium abundance and local inflammation in cases but not controls. The
Correlations were significant for IL-10 (r = 0.44, p = 0.01) and TNF-a (r = 0.33, p = 0.06). *p,0.05.
doi:10.1371/journal.pone.0053653.g003
Figure 4. Log Abundance of Fusobacterium in matched normal colon and colorectal cancer tissue. Fusobacterium abundance was
evaluated in DNA samples from normal colon and tumor tissue by qPCR using Fusobacterium-specific primers. Results suggest that Fusobacterium is
increased in colon cancer tissue compared to normal tissue (t-test p = 0.0005).
doi:10.1371/journal.pone.0053653.g004
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assess the actual adenomas specifically, compared to normal
mucosa. Our findings raise several important questions. With
regard to colorectal adenomas and cancer, is Fusobacterium
causative agent or an opportunistic colonizer? Does Fusobacterium
act alone or in concert with other bacteria, viruses or fungi to
promote CRC? Are there specific changes in the colonic
environment that contribute to increased abundance of Fusobac-
terium in carcinogenesis? What are the mechanisms involved in this
process? These questions will need to be addressed in future
studies, particularly in animal models of adenomas and CRC to
uncover whether Fusobacterium is a causative agent or opportunistic
colonizer of colorectal tissue. Several potential factors such as host
inflammation and altered gut environment (pH, bile acids,
presence of adenoma or cancer) may contribute to the relationship
between Fusobacterium and adenomas. These are addressed below.
Inflammation is a known risk factor for CRC [21,22].
Interestingly, intestinal inflammation has been repeatedly linked
to the gut microbiota [23,24]. Commensal gut bacteria interact
with the host in a symbiotic way to facilitate the operation of the
intestinal immune system. However, as reported by several studies,
bacterial dysbiosis may contribute to dysregulation of the immune
system and mucus production in the gut, ultimately disrupting the
delicate homeostatic relationship between commensal bacteria and
the human host [3,25,26]. Uronis et al. [26] successfully demon-
strated a link between the microbiota, intestinal inflammation and
increased risk of colitis-associated colorectal cancer (CAC) in a
mouse model. More specifically, Fusobacterium has been implicated
as a pro-inflammatory pathogen [25,27,28] and has been found in
a higher abundance of IBD patients [18].
Fusobacterium sp. have been found to flourish primarily in the oral
cavity where they have been observed to behighly invasive [18,29]
and adherent [30–32]. The ability of Fusobacterium to attach to
mucosal surfaces [28] makes it an ideal candidate to study in
relation to host immunity and adenomas. Given the reports of
previous studies that link Fusobacterium with inflammatory bowel
diseases (IBD), we evaluated its relationship with several inflam-
matory markers. Specifically, we assessed mRNA expression of
mucosal inflammatory cytokines IL-6, IL-10, IL-12, IL-17 and
TNF-a in normal rectal biopsies and correlated their expression
levels with abundance of Fusobacterium species in adenoma and
non-adenoma subjects. We observed a positive correlation
between the gene expression of several local cytokines and
Fusobacterium species in adenoma cases, but not in controls. Similar
to previously published findings [25], we saw a significant
association between increased abundance of Fusobacterium and
TNF-a. Dharmani et al. observed that the presence of invasive F.
nucleatum strains correlated with increased TNF-a expression in
IBD patients as well as experimental models [25]. Therefore,
taking into consideration the observations that Fusobacterium is
invasive and adherent, its link with IBD, its increased abundance
in adenoma cases compared to controls, as well as a positive
correlation with local inflammation, one could suggest that
Fusobacterium may contribute to increased mucosal inflammation
in adenoma subjects. However, we also detected a significant
positive correlation between Fusobacterium and IL-10 expression in
adenoma cases. While this observation with IL-10 is interesting, it
highlights the complex and multi-factorial relationship between
the host and its enteric intestinal bacteria.
The human host and the gut bacteria share a complex symbiotic
relationship in which they both exert considerable influence on
each other. Tumors are known to acidify their microenvironment
and cause fluctuations in pH, thus the presence of an adenoma or
cancer could lead to stress of the gut environment [33]. The
presence of adenoma or cancer could change the luminal
environment by altering levels of bile acids, pH, nutrient levels
and redox potential, all of which could impact the gut microbial
community and favor overgrowth of opportunistic pathogens.
Altered colonic pH could affect metabolic activity, absorption of
short-chain fatty acids (SCFA), and composition of gut microflora
and mucosal cell proliferation [34]. Walker et al. observed that
even a single unit change in pH affected the host microbial
community composition as well as production of SCFA, especially
among butyrate-producing species [35], a group within which
Fusobacterium is included [36–39]. While most bile acids aid
solubilization of lipids and facilitate nutrient absorption, some are
transformed by intestinal bacteria into toxic secondary bile acids in
the colon [40]. Thus, the transformation of secondary bile acids in
the colon could have cytotoxic effects that may contribute to
various gastrointestinal diseases including colorectal cancer [41–
43]. Therefore, it is possible that Fusobacterium is a commensal that
gains from the disruption of intestinal homeostasis as a result of the
presence of adenoma or cancer. We evaluated the relationship
between Fusobacterium species and adenoma size and frequency.
However, there were no significant relationships observed between
Fusobacterium and adenoma size (small, medium and large) or
number of adenomas, suggesting that the abundance Fusobacterium
in colonic mucosa is not impacted by adenoma size or frequency.
These results are consistent with the findings of Castellarin et al.
[10] who observed no association between Fusobacterium abun-
dance and colorectal cancer tumor stage, site, treatment, patient
age or survival.
Our goal was to study adenomas, precursors to colorectal
cancer, to assess whether an association with Fusobacterium was
present. We found an increased abundance of Fusobacterium among
adenoma cases compared to controls. Our findings that Fusobac-
terium is associated with colorectal adenomas implicate its possible
involvement early in carcinogenesis. Our work builds on the
findings of previous studies reporting an association between
Fusobacterium and colorectal cancer. [8,10,11]. Our observation of a
positive correlation between Fusobacterium and mucosal inflamma-
tion in adenoma cases suggests that this relationship may possibly
be mediated by inflammation. However, given the complex
environment in which Fusobacterium exists with other bacteria [18],
we exercise caution in assigning causality as we recognize that
more mechanistic studies are needed to elucidate such an
association. Recently the alpha-bug and driver-passenger models
of CRC proposed by Sears et al. and Tjalsma et al. respectively
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[44,45] defined bacterial drivers (or alpha bugs) as gut bacteria
with pro-carcinogenic features such as possession of virulence
factors, ability to directly modulate mucosal immune responses
and ability to alter bacterial community composition to favor
proliferation of opportunistic bacteria (passengers). Thus, under
these models Fusobacterium could be an important player. Future
studies in animal models could help tease apart the precise




Institutional approval was provided by University of North
Carolina, School of Medicine Institutional Review Board.
Study Population and Sampling
Two sets of human samples were analyzed in this study. The
first group of subjects was drawn from participants in the Diet and
Health Study V who underwent routine colonoscopy screening at
UNC Hospitals, Chapel Hill, NC. Eligible subjects 30 years of age
or older gave written informed consent to provide colorectal
biopsies as well as a phone interview involving questions about diet
and lifestyle. At the time of the colonoscopy procedure, the
research assistant obtained anthropometric measures to determine
body mass index (BMI) and waist–hip ratio (WHR) [13,20].
Biopsy samples from a total of 115 randomly selected subjects (48
adenoma cases and 67 non-adenoma controls) were used in this
study. Subjects with known or suspected colorectal cancer or with
inadequate colon prep were excluded from the study. Before the
endoscopy procedure was performed, biopsies were taken 8–
12 cm from the anal verge of the normal rectal mucosa, and
immediately flash frozen in liquid nitrogen. Biopsies were stored at
280uC. Participants with reported adenomas were classified as
‘‘cases’’ and those with no adenomas as ‘‘controls’’ [20].
The second group of samples was made up of de-identified
matched tumor and normal tissue biopsies from 10 patients with
colorectal cancer. Samples were obtained from UNC Tissue
Procurement Facility to confirm previously reported studies.
Fusobacterium Culture
Fusobacterium nucleatum subsp. nucleatum (ATCCH 25586TM) was
obtained from the American Type Culture Collection (ATCC)
and cultured according to their instructions for use as a positive
control. The strain was grown on Reinforced Clostridial Medium
(Difco, Becton Dickinson, Franklin Lakes, NJ) under anaerobic
conditions at 37uC.
DNA Extraction
DNA was extracted from normal rectal mucosal biopsies as well
as matched tumor/normal tissue using the Qiagen DNeasy Blood
and Tissue Kit (Cat# 69504) and a modified protocol with
lysozyme and bead-beating [13,20]. Pure cultures of F. nucleatum
were centrifuged, re-suspended in kit-provided lysis buffer, and
DNA extraction was performed using the same extraction method
used for biopsies.
Pyrosequencing of Colorectal Tumors and Matched
Normal Tissue
For CRC tumor and matched normal tissue, the pyrosequenc-
ing protocol is as described previously [20]. Briefly, the bacterial
16S rRNA gene was amplified from each DNA sample using
barcode-tagged universal 16S primers that span the V1–V3
variable regions. PCR amplification and detection were performed
using 454 GS FLX Titanium technology in the UNC Microbiome
Core Facility. The primers were composed of the Roche Titanium
Fusion Primer A (59-CGTATCGCCTCCCTCGCGCCATCAG-
39), a 10 bp MID barcode (Roche, Indianapolis, IN) unique to
each of the samples and the universal bacteria primer 27F (59-
AGAGTTTGATCCTGGCTCAG-39)The reverse primers were
composed of the Roche Titanium Primer B (59-
CTATGCGCCTTGCCAGCCCGCTCAG-39) the identical
10 bp MID as the forward primer and the reverse bacteria primer
338R (59-TGCTGCCTCCCGTAGGAGT-39) [46].
Analysis of Bacterial Pyrosequencing Data from CRC
Tissue
Analysis of deep sequencing data from CRC tumor and
matched normal tissue was performed using QIIME [47]. Briefly,
the combined raw sequencing data as well as metadata describing
the samples were de-multiplexed and filtered for quality control,
following which the data were denoised by PyroNoise and
sequences were grouped into OTUs (Operational Taxonomic
Units) at 97% sequence similarity to approximate genus-level
phylotypes. After taxonomic assignment of OTUs, sequences were
aligned for phylogenetic analysis as well as alpha and beta diversity
calculations. In addition to t-tests, Wilcoxon-rank sum test was
used to compare bacterial abundance and diversity in CRC tumor
versus normal tissue.
Quantitative Real-Time PCR (qPCR)
For mucosal samples from adenoma cases and non-adenoma
controls as well as CRC tumors and matching normal tissue,
qPCR was performed to quantify the abundance of Fusobacterium
species. A standard curve was generated by amplifying a16S
rDNA region of F. nucleatum (ATCCH 25586TM) using Fusobacte-
rium-specific primers [48]. Concentration of the PCR product was
measured by absorbance and the number of fragment copies was








Copy number was adjusted to a starting concentration of
1.0061010 and serial dilutions were performed to create nine
standards. 25 ml reactions were prepared containing template
DNA, 10mM primer mix, and Fast-SYBR Green Master Mix
(Applied Biosystems). The qPCR was performed with an
annealing temperature of 60uC for 40 cycles. Finally, the copy
number was calculated based on the standard curve, which was
adjusted to a starting DNA concentration of 50 ng/mL using the




where A is the concentration of the template DNA and B is the
dilution, 1:10.
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Reverse Transcriptase PCR (RT-PCR) for Local
Inflammatory Cytokines in Adenoma Cases and Non-
adenoma Controls
RT-PCR was performed to assess mRNA expression of
inflammatory cytokines IL-6, IL-10, IL-12, IL-17 and TNF-a
using ready-to-use optimized primers (SA Biosciences). Expression
of each inflammatory cytokine was assessed relative to the
housekeeping gene hydroxymethylbilane synthase (HMBS). The
qPCR was performed using SYBR Green Master Mix (Applied
Biosystems) and each sample was run in duplicate. qPCR results
were normalized using the expression of the HMBS gene [49].
Fluorescence in situ Hybridization (FISH)
FISH was performed on paraffin sections of mucosal biopsies
fixed with Carnoy’s fixative using a universal bacteria probe
(EUB388) and a Fusobacterium-specific probe. These assays used a
previously described protocol [13]. Pure cultures of E. Coli and
Fusobacterium were used as positive controls.
Statistical Analysis
Mean and standard errors were computed for continuous
variables. Comparison of continuous variables such as age (years),
waist hip-ratio, body mass index (Kg/m2), alcohol (grams/day)
calories (Kcal/day), fat (grams/day), red meat (ounces/day) and
dietary fiber intake (grams/day) between adenoma cases and non-
adenoma controls were made using t-tests. Categorical variables
for CRC subjects (tumor location, disease stage, adjuvant therapy)
were compared by Fisher’s Exact Test. Fusobacterium copy numbers
were assessed for normality and log transformed. Mean log
Fusobacterium abundance was compared between case and control
subjects using t-test. The distribution of Fusobacterium among
control subjects were used to generate tertile values for logistic
regression analysis. The lowest tertile of Fusobacterium abundance
was considered as the reference. Correlation of Fusobacterium and
local gene expression of TNF-a, IL-17, IL-12, IL-10 and IL-6
were assessed by Spearman’s correlation coefficient.
Supporting Information
Table S1 Relationship between Fusobacterium abun-
dance and adenoma size.
(DOCX)
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